Will France succeed in legalizing medical cannabis? At the beginning of the year, France's Agence Nationale de Sécurité du Médicament (ANSM) assured us that medical...
Launched in 2021, the medical cannabis experiment in France has reached its participation target with 3,035 patients now joining the program, including...
On Wednesday October 25, the Prime Minister pledged the Government's responsibility for the «expenditure» section of the Social Security Financing Bill...
After having chosen not to include the generalization of medical cannabis in the Social Security Financing Bill, after having rejected...
As we reported in two parts last week, a number of amendments have finally been tabled (PDF) in an attempt to include the...
A previous version of the article, which stuck to the Minister's words in the Commission, reported the Ministry of Health's refusal to generalize the...
The «Accès aux soins.fr» platform is a citizens' initiative aimed at raising awareness among members of parliament of the need to legalize medical cannabis in...
As Newsweed revealed as early as last week, the Social Security Financing Bill (PLFSS) published this Wednesday does not include...
According to our information, the legalization of medical cannabis for 2024 will not be carried by the Macron government. The future French Finance Bill (Projet de...
While the PLFSS 2024 will go before parliament this autumn, negotiations are underway to decide which themes to include in next year's budget...
Australia's Little Green Pharma (LGP), which already supplies CBD:THC 20:1 oil to the French medical cannabis trial, has won the second tender to supply...
Aurora and Ethypharm have once again been selected by the French Direction Générale de la Santé (DGS) as exclusive suppliers of dried medical cannabis flowers...
Australian company Little Green Pharma (LGP) will continue to supply its 20:1 CBD oils to medical cannabis trials in France. It has also applied to the...
At a progress report organized last Friday by the Direction Générale de la Santé (DGS) for interested stakeholders, the French health authorities...
After the most prescribed product in the therapeutic cannabis experiment ran out of stock, the health authorities recommended switching to an oil...
While, according to many previously relayed testimonies, the Direction Générale de la Santé (DGS) had not correctly anticipated the extension of medical cannabis experimentation,...
Patients' fears proved real. Last week, we reported on the possible shortage of medical cannabis products in France, and now a...
Edit of 22/03 at 11:35: DGS response added at bottom of article. This is a real alert for patients included in the experiment...
The experiment with medical cannabis in France, aimed at a maximum quota of 3,000 patients, has met with an extremely positive response from...
After 4 years of discussions around the experimentation of therapeutic cannabis in France, and its launch almost 2 years ago, the Direction Générale de...
